COMP <GO>
NPCE vs CARL // DIVIDEND YIELD & FCF PAYOUT SAFETY
Neuropace Inc. (NASDAQ) VS. Carlsmed Inc. (NASDAQ) • 15-METRIC TALLY: NPCE 7
— CARL 2
■ METRIC PARITY
LAST: $13.01 (+0.62%) • MKT CAP: $446.6M
dividend-safety
0.00%
LAST: $15.77 (+3.01%) • MKT CAP: $430.6M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NPCE VS. CARL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NPCE | CARL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.20% | 75.30% | +1.90 | NPCE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.00% | -35.00% | +12.00 | NPCE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.54% | -6.88% | +4.34 | NPCE | /fcf-yield <GO> |
| Operating Margin | -16.30% | -60.00% | +43.70 | NPCE | /operating-margins <GO> |
| Net Profit Margin | -21.50% | -58.70% | +37.20 | NPCE | /net-margins <GO> |
| Revenue Growth (YoY) | 25.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 7.83 | -7.63 | CARL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | NPCE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.7 | 59.5 | -10.80 | CARL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $446.6M | $430.6M | $16.0M | NPCE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NPCE REV | CARL REV | NPCE GROSS % | CARL GROSS % | NPCE FCF | CARL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.0M | $50.5M | 77.2% | 75.3% | -$11.3M | -$29.6M |
| FY 2024 | $79.9M | $27.2M | 73.9% | 73.8% | -$18.3M | -$25.6M |
| FY 2023 | $65.4M | — | — | — | -$19.7M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NPCE // BETA —
CARL // BETA —